题名

遺傳/罕見疾病簡介與遺傳諮詢的運用

并列篇名

Introduction to Genetic/Rare Disease and the Application of Genetic Counseling

DOI

10.6224/JN.000063

作者

朱紹盈(Shao-Yin Chu);翁純瑩(Chun-Ying Weng)

关键词

遺傳/罕見疾病 ; 遺傳性 ; 遺傳諮詢 ; genetic disease/rare disease ; heritability ; genetic counseling

期刊名称

護理雜誌

卷期/出版年月

64卷5期(2017 / 10 / 01)

页次

11 - 17

内容语文

繁體中文

中文摘要

遺傳疾病指的是因遺傳物質或遺傳因素改變所造成的疾病,有些會遺傳給下一代或是由上一代遺傳而來,所以具遺傳性是其特點,也就是同樣的疾病會在同一個家族中重複出現。在臺灣,小於萬分之一年盛行率的疾病即定義為罕見疾病。大部份(80%)的罕見疾病是遺傳疾病,但遺傳疾病不一定是罕見疾病。遺傳疾病的致病機轉非常複雜,每一個疾病都有自己獨特的機轉,無法用單一病變機制說明,常常是不明原因,使得遺傳疾病的臨床表現極其多樣化,極端不容易分類和診斷。許多遺傳疾病的患者多會合併發育發展遲緩、器官缺損(如:智障、聽障、視障等)、先天性異常、神經肌肉疾病等。除症狀治療與支持性療法外,只有少數遺傳疾病可以治療(如:部份溶小體儲積症的酵素替代療法,先天性代謝異常的特殊嬰兒配方奶粉)。生活無法自理很常見,家屬身心的負擔也很大。所以完善的復健計畫、早期療育,個別化的照護方案,遺傳諮詢,家庭支持團體的成立皆扮演著重要的角色之外,完善的社會福利制度及大眾的接納更是重要。遺傳/罕見疾病個別的發生率雖低,但整體而言他們是一群不能忽視的疾病。國家政策的制定與立法、疾病登錄系統、全人照護網絡的建置、研究等相關的議題仍舊是一個挑戰。

英文摘要

Genetic disease or hereditary disease is a group of disorders that is caused by mutations in an individual's genome. The mutated genome or gene may be transmitted through the germ line during reproduction, causing certain recurrence risk in offspring and other family members. The heritability of these disorders is thus an important issue to deal with clinically. In Taiwan, a rare disease is defined as a disease that is prevalent in fewer than 1 in 10,000 individuals. As up to 80% of rare disease cases in Taiwan are genetic disease disorders, genetic disease may not rare. The pathophysiology of genetic/ rare disease is very complicated. Individual disorders may have their own unique mechanisms (such as Fragile X syndrome), with most of these mechanisms still unclear or unknown. The symptoms and signs of genetic/rare disease thus present the greatest variabilities and cause difficulties in making diagnoses. Most related patients may present multiple congenital anomalies, metabolic disorders, growth and developmental delays, defects in cognition, neuromuscular abnormalities, and defects in vision, hearing or other organ functions. Symptomatic and supportive treatment still comprise a major component of treatment of genetic/rare disease (with the exception of special formulae for several inborn errors of metabolic disease and enzyme replacement therapy in some lysosomal storage disease). Poor self-care ability is common and the burden on caregivers is huge. Most rare disease patients are treated using a comprehensive rehabilitation program that begins during very early childhood, receive individual educational programs, and are continuously monitored with regard to their growth, developmental, and nutritional status. Inter-professional patient care, genetic counseling, and the creation of family support networks play an important role in family management. Public awareness and the creation of appropriate social systems and resources allocation are mandatory for proper care. The incidence of each genetic/rare disease is rare, but collectively they are important public health issue and a challenge to medical care.

主题分类 醫藥衛生 > 預防保健與衛生學
醫藥衛生 > 社會醫學
参考文献
  1. National Human Genome Research Institute. (2015, November 10). Frequently asked questions about genetic disorders. Retrieved from https://www.genome.gov/19016930/FAQAbout-Genetic-Disorders
  2. World Health Organization. (n.d.). Rare diseases. http://www.who.int/medicines/areas/priority_medicines/Ch6_19Rare.pdf
  3. Stöppler, M. C. (2016). What is a genetic disease? Retrieved from MedicineNet.com website: http://www.medicinenet.com/genetic_disease/article.htm#what_is_a_genetic_disease
  4. 國民健康署(2017,4月25日).公告罕見疾病名單暨ICD-10-CM編碼一覽表.取自http://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=596&pid=1065 [Health Promotion Administration, Taiwan, ROC. (2017, April 25). Rare disease. Retrieved from http://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=596&pid=1065]
  5. National Society of Genetic Counselors. (n.d.). About genetic counselors. Retrieved from http://www.nsgc.org/page/aboutgeneticcounselors
  6. 國民健康署(2015,1月28日).新生兒先天性代謝異常疾病篩檢項目公告.取自https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=499&pid=397 [Health Promotion Administration, Taiwan, ROC. (2015, January 28). Neonatal screen list metabolic of inborn errors. Retrieved from https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=499&pid=397]
  7. Trudeau Institute. (n.d.). Dr. Edward Livingston Trudeau. Retrieved from http://trudeauinstitute.org/dynamicPages/template.cfm?ID=140&navTable=tier2nav
  8. 國民健康署(2015,5月29日).新生兒先天性代謝異常疾病篩檢∼作業手冊(採集機構版本)104 年修訂版.取自ttps://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=499&pid=405 [Health Promotion Administration, Taiwan, ROC. (2015, May 29). Operation manual for neonatal screen metabolic of inborn errors- 2015 revised. Retrieved from https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=499&pid=397]
  9. Biesecker, B.,Austin, J.,Caleshu, C.(2016).Response to a different vantage point commentary: Psychotherapeutic genetic counseling, is it?.Journal of Genetic Counseling,26(2),334-336.
  10. Collins, F. S.,McKusick, V. A.(2001).Implications of the human genome project for medical science.JAMA: Journal of the American Medical Association,285(5),540-544.
  11. Cooper, D. N.,Krawczak, M.,Polychronakos, C.,Tyler-Smith, C.,Kehrer-Sawatzki, H.(2013).Where genotype is not predictive of phenotype: Towards an understanding of the molecular basis of reduced penetrance in human inherited disease.Human Genetics,132(10),1077-1130.
  12. Greendale, K.,Pyeritz, R. E.(2001).Empowering primary care health professionals in medical genetics: How soon? How fast? How far?.American Journal of Medical Genetics,106(3),223-232.
  13. Norton, M. E.(2008).Genetic screening and counseling.Current Opinion in Obstetrics & Gynecology,20(2),157-163.
  14. Raghuveer, T. S.,Garg, U.,Graf, W. D.(2006).Inborn errors of metabolism in infancy and early childhood: An update.American Family Physician,73(11),1981-1990.
  15. Reed, S. C.(1974).A short history of genetic counseling.Social Biology,21(4),332-339.
  16. Resta, R.,Biesecker, B. B.,Bennett, R. L.,Blum, S.,Hahn, S. E.,Strecker, M. N.,Williams, J. L.(2006).A new definition of genetic counseling: National Society of Genetic Counselors' task force report.Journal of Genetic Counseling,15(2),77-83.
  17. Rose, N. C.,Wick, M.(2017).Carrier screening for single gene disorders.Seminars in Fetal & Neonatal Medicine
  18. Song, P. P.,Gao, J. J.,Inagaki, Y.,Kokudo, N.,Tang, W.(2012).Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives.Intractable & Rare Disease Research,1(1),3-9.
  19. Verrotti, A.,Carelli, A.,Coppola, G.(2014).Epilepsy in children with Menkes disease: A systematic review of literature.Journal of Child Neurology,29(12),1757-1764.
  20. Zhong, A.,Darren, B.,Dimaras, H.(2017).Ethical, social, and cultural issues related to clinical genetic testing and counseling in low- and middle-income countries: Protocol for a systematic review.Systematic Reviews,6(1),article 140.
  21. 王美仁、林秀娟、蔡文暉(2004)。產、兒科醫護人員對遺傳諮詢倫理議題之質性研究。慈濟醫學雜誌,16(2),111-118。
被引用次数
  1. (2024)。罕見疾病患者主要照顧者社會支持、希望感與復原力之相關研究。台灣健康照顧研究學刊,30,82-100。